Your browser doesn't support javascript. This means that the content or functionality of our website will be limited or unavailable. If you need more information about Vinnova, please contact us.

Dual Purpose Virtual Reality (VR) Team Training for Civilian and Military Medics

Reference number
Coordinator Simlogic AB
Funding from Vinnova SEK 1 300 000
Project duration November 2024 - July 2025
Status Ongoing
Venture Civil-military synergies
Call Acceleration of Civil-Military Innovations 2024

Important results from the project

The project resulted in a VR-based simulation platform for military medical team training, featuring customizable scenarios and support for realistic training in combat environments. The goal of creating a dual-use solution was achieved. The platform enhances readiness and decision-making among military medical personnel and can also be used in civilian contexts. It has the potential to contribute to total defense, export opportunities, and continued innovation.

Expected long term effects

The project is expected to increase the Swedish Armed Forces’ knowledge and capabilities in military medical training through VR technology. Its dual-use application strengthens both total defense and civilian crisis preparedness. The platform’s scalability and export potential can contribute to Sweden’s innovation capacity, international collaboration, and the development of defense-related health technology.

Approach and implementation

The project is expected to lead to increased knowledge about in "Forsvarsmakten" about military medical readiness through accessible and realistic team training in VR. Its dual-use capability strengthens both total defense and civilian crisis preparedness. The platform’s scalability and export potential can enhance Sweden’s competitiveness in defense-related health technology and create new opportunities for innovation, education, and international collaboration.

The project description has been provided by the project members themselves and the text has not been looked at by our editors.

Last updated 3 September 2025

Reference number 2024-03316